Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Thoracic Aorta01:15

Thoracic Aorta

The thoracic section of the aorta begins at the T5 vertebra and extends to the T12 level at the diaphragm, initially progressing through the mediastinum to the left of the spinal column. Throughout its course in the thoracic segment, the thoracic aorta emits various offshoots known collectively as visceral and parietal branches. The branches that predominantly supply blood to visceral organs are termed visceral branches and include bronchial, pericardial, esophageal, and mediastinal arteries,...
The Aorta01:14

The Aorta

The aorta is the largest artery in the human body. It originates from the left ventricle of the heart and extends down to the abdomen, where it splits into two smaller arteries. Structurally, it can be divided into four main parts: the ascending aorta, the aortic arch, the thoracic aorta, and the abdominal aorta.
The average diameter of the aorta is approximately 2-3 cm, but the size can vary depending on the section of the aorta and the individual's age, sex, and body size. The aorta is...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Abdominal Aorta01:25

Abdominal Aorta

Once the aorta traverses the diaphragmatic plane at the aortic hiatus, it is known as the abdominal aorta. This anatomical structure is positioned leftward of the spinal column, encased within a cocoon of adipose tissue behind the peritoneal cavity. It terminates at the L4 vertebra, where it splits into the common iliac arteries. Prior to this bifurcation, the abdominal aorta gives rise to several vital branches.
The celiac trunk, a singular artery, divides into the left gastric artery, which...
The Arch of Aorta01:10

The Arch of Aorta

The coronary arteries, originating from the ascending aorta, bifurcate from two sinuses located within the ascending aorta. Positioned just above the aortic semilunar valve, these sinuses house essential aortic baroreceptors and chemoreceptors, crucial for maintaining cardiac function. The left coronary artery and the right coronary artery branch off from the left posterior and anterior aortic sinuses, respectively.
Encircling the heart, the coronary arteries form a ring-like structure before...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Perspectives on Cardiac Rehabilitation and Exercise After Spontaneous Coronary Artery Dissection.

Heart, lung & circulation·2026
Same author

Polygenic Prediction of Nongoal Response to Statin Therapy.

Circulation. Genomic and precision medicine·2026
Same author

ALIGN-FMD Leducq funded network: Demystifying Fibromuscular Dysplasia.

European heart journal·2026
Same author

Cardiovascular risks and hazards associated with deep space exploration.

Communications medicine·2026
Same author

Multimodal atlas of human atherosclerosis links granular vascular cell states to coronary artery disease risk.

medRxiv : the preprint server for health sciences·2026
Same author

Macrophage EHD1 Promotes Inflammation and Stabilizes Sortilin to Accelerate Atherosclerosis.

Circulation research·2026

Related Experiment Video

Updated: May 22, 2026

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
04:56

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Published on: August 1, 2025

Are we ignoring the dilated thoracic aorta?

Jose M Castellano1,2, Jason C Kovacic1,2, Javier Sanz1,2

  • 1Zena and Michael A. Wiener Cardiovascular Institute.

Annals of the New York Academy of Sciences
|May 3, 2012
PubMed
Summary

Thoracic aortic aneurysms (TAA) differ from abdominal aortic aneurysms (AAA) and Marfan syndrome. Current treatments are based on weak data, necessitating distinct clinical trials for TAA therapies.

More Related Videos

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
06:08

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Published on: March 8, 2019

An Approach to Point-Of-Care Ultrasound Evaluation of the Abdominal Aorta
07:12

An Approach to Point-Of-Care Ultrasound Evaluation of the Abdominal Aorta

Published on: September 8, 2023

Related Experiment Videos

Last Updated: May 22, 2026

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
04:56

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Published on: August 1, 2025

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
06:08

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions

Published on: March 8, 2019

An Approach to Point-Of-Care Ultrasound Evaluation of the Abdominal Aorta
07:12

An Approach to Point-Of-Care Ultrasound Evaluation of the Abdominal Aorta

Published on: September 8, 2023

Area of Science:

  • Cardiovascular Research
  • Genetics and Pathophysiology
  • Aortic Disease

Background:

  • Thoracic aortic aneurysm (TAA) formation is complex, involving genetics, cardiovascular risk factors, and hemodynamics.
  • Current pharmacologic treatments for TAA are extrapolated from abdominal aortic aneurysms (AAA) or Marfan syndrome, lacking robust evidence.
  • Significant differences exist in the etiology and progression of TAA, familial TAA, and AAA, suggesting they are distinct disease processes.

Purpose of the Study:

  • To highlight the distinct pathophysiology of thoracic aortic aneurysms (TAA) compared to other aortic diseases.
  • To critique the current practice of applying treatments from abdominal aortic aneurysms (AAA) or Marfan syndrome to TAA.
  • To emphasize the need for dedicated clinical trials for TAA before recommending specific medical therapies.

Main Methods:

  • Review of existing epidemiologic and experimental data on TAA, AAA, and Marfan syndrome.
  • Analysis of the interplay between genetic and non-genetic risk factors in aneurysm development.
  • Comparative assessment of physiological processes underlying different aneurysm types.

Main Results:

  • TAA, familial TAA, and AAA involve diverse genetic and non-genetic risk factors and physiological processes.
  • Extrapolation of data between different aneurysm types is ill-founded and potentially harmful.
  • Current medical therapies lack sufficient evidence for TAA treatment.

Conclusions:

  • Thoracic aortic aneurysms (TAA) should be treated as distinct entities, separate from abdominal aortic aneurysms (AAA) and Marfan syndrome.
  • Clinical trials are essential to establish evidence-based medical therapies for TAA.
  • Pharmacologic agents like beta-blockers, ACE inhibitors, ARBs, statins, and macrolides require specific TAA trial data for recommendation.